Loading...

BioGaia AB (publ)

BIOGY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$11.00
$0.00(0.00%)
U.S. Market opens in 14h 20m

BioGaia AB (publ) (BIOGY) Stock Overview

Explore BioGaia AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio30.71
EPS (TTM)$0.35
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$13.05
3 Months$11.42
1 Year Target$9.67

BIOGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioGaia AB (publ) (BIOGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.71 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-11.00%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-2.22%
Year-to-Date (YTD) Change
N/A
1-Year Change
16.16%
3-Year Change
31.26%
5-Year Change
7.84%
All-Time (Max) Change
69.23%

Contact Information

https://www.biogaia.com
46 8 55 52 93 00
Kungsbroplan 3, Stockholm, NaN, 112 27

Company Facts

2,240 Employees
IPO DateJan 8, 2021
CountrySE
Actively Trading

Frequently Asked Questions